Order Article Reprints

Frade-Sosa B, Chacur CA, Augé JM, Ponce A, Sarmiento-Monroy JC, Azuaga AB, Sapena N, Ramírez J, Ruiz-Esquide V, Morlà R, et al. Calprotectin in Patients with Rheumatic Immunomediated Adverse Effects Induced by Checkpoints Inhibitors. Cancers. 2023; 15(11):2984. https://doi.org/10.3390/cancers15112984

Frade-Sosa, Beatriz, Chafik Alejandro Chacur, Josep M. Augé, Andrés Ponce, Juan C. Sarmiento-Monroy, Ana Belén Azuaga, Nuria Sapena, Julio Ramírez, Virginia Ruiz-Esquide, Rosa Morlà, and et al. 2023. "Calprotectin in Patients with Rheumatic Immunomediated Adverse Effects Induced by Checkpoints Inhibitors" Cancers 15, no. 11: 2984. https://doi.org/10.3390/cancers15112984

Frade-Sosa, B., Chacur, C. A., Augé, J. M., Ponce, A., Sarmiento-Monroy, J. C., Azuaga, A. B., Sapena, N., Ramírez, J., Ruiz-Esquide, V., Morlà, R., Farietta, S., Corzo, P., Cañete, J. D., Sanmartí, R., & Gómez-Puerta, J. A. (2023). Calprotectin in Patients with Rheumatic Immunomediated Adverse Effects Induced by Checkpoints Inhibitors. Cancers, 15(11), 2984. https://doi.org/10.3390/cancers15112984